Immunogenetic risks of anti-cyclical citrullinated peptide antibodies in a North American Native population with rheumatoid arthritis and their first-degree relatives

Journal of Rheumatology

Volumn 36, Issue 6, 2009, Pages 1130-1135

  El Gabalawy, Hani S ^a   Robinson, David B ^a   Hart, Donna ^a   Elias, Brenda ^a   Markland, Janet ^b   Peschken, Christine A ^a   Smolik, Irene ^a   Montes Aldana, Gabriela ^a   Schroeder, Marlis ^a   Fritzler, Marvin J ^c   Cheang, Mary ^a   Oen, Kiem ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti cyclical citrullinated peptide antibodies; Immunogenetic risk; North American Native; Pathogenesis; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPITOPE; HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; CANADA; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; INDIANS, NORTH AMERICAN; MALE; PEPTIDES, CYCLIC; SEQUENCE ANALYSIS, DNA;

EID: 67149084969     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080855     Document Type: Article

References (29)

1. Peschken CA, Esdaile JM. Rheumatic diseases in North America's indigenous peoples. Semin Arthritis Rheum 1999;28:368-391 (Pubitemid 29289375)
2. Oen K, Robinson DB, Nickerson P, et al. Familial seropositive rheumatoid arthritis in North American Native families: effects of shared epitope and cytokine genotypes. J Rheumatol 2005;32:983-991 (Pubitemid 40828067)
3. Oen K, El-Gabalawy HS, Canvin JM, et al. HLA associations of seropositive rheumatoid arthritis in a Cree and Ojibway population. J Rheumatol 1998;25:2319-2323 (Pubitemid 28551846)
4. Ferucci ED, Templin DW, Lanier AP. Rheumatoid arthritis in American Indians and Alaska Natives: a review of the literature. Semin Arthritis Rheum 2005;34:662-667 (Pubitemid 40193364)
5. Templin DW, Boyer GS, Lanier AP, et al. Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associations. J Rheumatol 1994;21:1238-1244 (Pubitemid 24234658)
6. Hirsch R, Lin JP, Scott WW Jr, et al. Rheumatoid arthritis in the Pima Indians: the intersection of epidemiologic, demographic, and genealogic data. Arthritis Rheum 1998;41:1464-1469
7. Lee HS, Lee KW, Song GG, Kim HA, Kim SY, Bae SC. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum 2004;50:3468-3475 (Pubitemid 39488671)
8. Kong KF, Yeap SS, Chow SK, Phipps ME. HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia. Autoimmunity 2002;35:235-239 (Pubitemid 34904925)
9. Gonzalez A, Nicovani S, Massardo L, et al. Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis. Weak association between HLA-DR4 and rheumatoid arthritis in Chilean patients. Arthritis Rheum 1992;35:282-289
10. Nelson JL, Boyer G, Templin D, et al. HLA antigens in Tlingit Indians with rheumatoid arthritis. Tissue Antigens 1992;40:57-63.
11. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-2749 (Pubitemid 37280601)
12. Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-386 (Pubitemid 38198821)
13. Majka DS, Deane KD, Parrish LA, et al. Duration of pre-clinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis 2008;67:801-807 (Pubitemid 351829380)
14. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006;54:1117-1121 (Pubitemid 43672924)
15. Huizinga TW, Amos CI, van der Helm-van Mil AH, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005;52:3433-3438 (Pubitemid 41612209)
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324
17. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-392
18. Oen K, Schroeder M, Jacobson K, et al. Juvenile rheumatoid arthritis in a Canadian First Nations (aboriginal) population: onset subtypes and HLA associations. J Rheumatol 1998;25:783-790 (Pubitemid 28212392)
19. Khanna D, Wu H, Park G, et al. Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum 2006;54:1105-1116 (Pubitemid 43672923)
20. Greenberg J, Turner CI, Zegura S. The settlement of the Americas: A comparison of the linguistic, dental, and genetic evidence. Curr Anthropol 1986;27:411-497
21. Boyer GS, Templin DW, Lanier AP. Rheumatic diseases in Alaskan Indians of the southeast coast: high prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1991;18:1477-1484
22. Williams RC, Jacobsson LT, Knowler WC, et al. Meta-analysis reveals association between most common class II haplotype in full-heritage Native Americans and rheumatoid arthritis. Hum Immunol 1995;42:90-94
23. Oen K, Postl B, Chalmers IM, et al. Rheumatic diseases in an Inuit population. Arthritis Rheum 1986;29:65-74. (Pubitemid 17015408)
24. Hansen JA, Lanier AP, Nisperos B, Mickelson E, Dahlberg S. The HLA system in Inupiat and Central Yupik Alaskan Eskimos. Hum Immunol 1986;16:315-328 (Pubitemid 16040250)
25. Bias WB, Hsu SH, Pollard MK, et al. HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis. Hum Immunol 1981;2:155-163 (Pubitemid 12249565)
26. Ioan-Facsinay A, Willemze A, Robinson DB, et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 2008;58:3000-3008
27. Berglin E, Padyukov L, Sundin U, et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 2004;6:R303-8.
28. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46. (Pubitemid 43122184)
29. Willemze A, Ioan-Facsinay A, El-Gabalawy H. Anti-citrullinated protein antibody response associated with synovial immune deposits in a patient with suspected early rheumatoid arthritis. J Rheumatol 2008;35:2282-2284